Bio-Rad Laboratories, Inc. Class A Common Stock vs Enbridge Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Enbridge Inc trades at $51.66 (market cap $112.62B). The key difference: Enbridge Inc is far larger — about 11.9× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Enbridge Inc pays a 5.34% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | ENB | |
|---|---|---|
Market Cap | $9.43B | $112.62B |
Sector | Health | Energy |
52-Week High | $356.25 | $58.04 |
52-Week Low | $241.71 | $45.23 |
Enterprise Value | $9.18B | $196.53B |
Dividend Yield | — | 5.34% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →